This page shows the latest NICE news and features for those working in and with pharma, biotech and healthcare.
Eli Lilly’s Verzenios (abemaciclib) has been recommended by the National Institute for Health and Care Excellence (NICE) as a treatment for early-stage breast cancer in combination with endocrine therapy. ... The NICE approval of Verzenios in
The deal comes after the National Institute for Health and Care Excellence’s (NICE) draft guidance recommending Fetcroja, issued in April 2022, for the treatment of severe multidrug-resistant aerobic ... exist. Fetcroja is one of two antimicrobial
Amarin’s Vazkepa (icosapent ethyl) has been recommended by the National Institute for Health and Care Excellence (NICE) for adults receiving statin treatment who are deemed to be at high cardiovascular ... Vazkepa is a new active substance, made up of
for Health and Care Excellence (NICE), that balances the weights of cost versus the benefit of drugs used by the NHS. ... The treatment would be made available to patients in need while data is assessed by NICE to determine whether the medicine is
NICE’s decision was based on positive results from the EMPOWER-CSCC-1 trial. ... NICE first recommended that Libtayo should be made available through the Cancer Drugs Fund (CDF) in 2019.
The collaboration agreement, signed by Inserm Transfert on behalf of Inserm, Centre Hospitalier Universitaire of Nice and University of Nice Côte d’Azur, aims to identify and develop a novel class
More from news
Approximately 420 fully matching, plus 838 partially matching documents found.
Creativity is more than just nice pictures and some nice words.
The National Institute for Health and Care Excellence (NICE) in the UK has long used cost- effectiveness assessments as the centre of its HTA, price and reimbursement process.
You only need look at the National Institute for Health and Care Excellence (NICE) pathways in adult Type 2 Diabetes (T2D) to see how many specialists are involved, including the diabetologist,
They may be advocating for their fellow patients behind the scenes, lobbying NICE for access to medicines, or publicising fundraising efforts via their local media.
For example, the UK health technology appraiser, NICE, is undergoing a review of its methodology to ensure that it can be more flexible in evaluating complex innovations such as personalised medicines.
More from intelligence
Approximately 12 fully matching, plus 134 partially matching documents found.
He was appointed in April 1999 when NICE was first established under Tony Blair’s ‘New Labour’ government. ... I am delighted that Gill has been appointed as NICE’s next chief executive.
The Association of the British Pharmaceutical Industry (ABPI) has attracted Professor Carole Longson away from the National Institute for Health and Care Excellence (NICE) to be its new chief scientific officer, ... She most recently spent the 18 years
Freeman's role is also tied into the Department for Business, Innovation and Skills and includes expanded responsibility for the Cancer Drugs Fund, NICE and MHRA, research and development, issues around
She has over 15 years' experience working in medical education and is a member of the ISMPP Ethics Committee, the NICE Implementation External Reference Group and part of the Royal Berkshire
Care Excellence (NICE) from its formation in 1999 to his departure last year.
More from appointments
Approximately 4 fully matching, plus 10 partially matching documents found.
37. While the app is approved for sale in the UK and can be advertised to the public, NICE still argues that there is not yet sufficient evidence for the app ... Published September 10, 2018. Accessed November 4, 2021. Wilkinson E. NICE: More evidence
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current ‘avoidance’ approach to allergies and how this impacts
While Pharma was already slowly pivoting towards virtual events as a substitute for, or supplement to, in-person meetings, COVID-19 quickly changed virtual events from a nice-to-have to
expensive treatment (even going outside of NICE guidance) because of this prioritised aspect of product value.
Yet, it’s so nice that I’ve not felt disconnected from the company at all, considering most of my interaction with the team has been online.
More from PMHub
Approximately 2 fully matching, plus 57 partially matching documents found.
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....